Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response

Abstract Background Lymphoma is the most common primary hematological malignancy. FDG PET/CT has recently become the standard imaging modality for clinical management owing to its ability to provide precise, non-invasive anatomical and functional data. The purpose of this study was to highlight the...

Full description

Bibliographic Details
Main Authors: Salma M. Borg, Gehad A. Saleh, Nihal M. Batouty, Amani Ezzat Mousa
Format: Article
Language:English
Published: SpringerOpen 2024-04-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43055-024-01247-6
_version_ 1827284422791004160
author Salma M. Borg
Gehad A. Saleh
Nihal M. Batouty
Amani Ezzat Mousa
author_facet Salma M. Borg
Gehad A. Saleh
Nihal M. Batouty
Amani Ezzat Mousa
author_sort Salma M. Borg
collection DOAJ
description Abstract Background Lymphoma is the most common primary hematological malignancy. FDG PET/CT has recently become the standard imaging modality for clinical management owing to its ability to provide precise, non-invasive anatomical and functional data. The purpose of this study was to highlight the role of 18F FDG-PET/CT in the management of lymphoma by monitoring treatment response, providing a guide for response-adapted therapy, and predicting the final therapeutic outcome. Methods This was a prospective monocentric cohort observational study in which thirty-three patients with histopathologically proved lymphoma of different types performed FDG-PET/CT scanning several times throughout the 24-month duration of the study. Early-stage interim SUVmax of the most active lesion (both nodal and/or extra-nodal) was measured and statistically analyzed together with data of the international prognostic index parameters and score. Results Among the included 33 patients of lymphoma, international prognostic index parameters and score together with the early-stage interim SUVmax of the predominant nodal and extra-nodal sites showed statistical significance in predicting the initial as well as the final treatment response after 24 months. Using ROC analysis, we could obtain cutoff values of SUVmax of the predominant nodal lesion of 2.75 (AUC 72%, 95% CI 0.42–1.0) and SUVmax of the predominant extra-nodal lesion of 3 (AUC 70.8% and 95% CI 0.23–1.0); therefore, SUVmax of higher than these values was related to stable or progressive disease, and lower levels than these values were related to complete or partial metabolic response based on Deauville 5-point scale and Lugano response criteria. Conclusions Early-stage interim PET-CT SUVmax of the predominant nodal and extra-nodal lesion could be a reliable parameter in predicting initial and final therapeutic outcome in lymphoma patients.
first_indexed 2024-04-24T09:55:56Z
format Article
id doaj.art-f309fa7933804efa8a75fd1b9a7517a7
institution Directory Open Access Journal
issn 2090-4762
language English
last_indexed 2024-04-24T09:55:56Z
publishDate 2024-04-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-f309fa7933804efa8a75fd1b9a7517a72024-04-14T11:11:02ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine2090-47622024-04-0155111210.1186/s43055-024-01247-6Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment responseSalma M. Borg0Gehad A. Saleh1Nihal M. Batouty2Amani Ezzat Mousa3Diagnostic Radiology Specialist at Ministry of Health and PopulationDiagnostic and Interventional Radiology Department, Faculty of Medicine, Mansoura UniversityDiagnostic and Interventional Radiology Department, Faculty of Medicine, Mansoura UniversityDiagnostic and Interventional Radiology Department, Faculty of Medicine, Mansoura UniversityAbstract Background Lymphoma is the most common primary hematological malignancy. FDG PET/CT has recently become the standard imaging modality for clinical management owing to its ability to provide precise, non-invasive anatomical and functional data. The purpose of this study was to highlight the role of 18F FDG-PET/CT in the management of lymphoma by monitoring treatment response, providing a guide for response-adapted therapy, and predicting the final therapeutic outcome. Methods This was a prospective monocentric cohort observational study in which thirty-three patients with histopathologically proved lymphoma of different types performed FDG-PET/CT scanning several times throughout the 24-month duration of the study. Early-stage interim SUVmax of the most active lesion (both nodal and/or extra-nodal) was measured and statistically analyzed together with data of the international prognostic index parameters and score. Results Among the included 33 patients of lymphoma, international prognostic index parameters and score together with the early-stage interim SUVmax of the predominant nodal and extra-nodal sites showed statistical significance in predicting the initial as well as the final treatment response after 24 months. Using ROC analysis, we could obtain cutoff values of SUVmax of the predominant nodal lesion of 2.75 (AUC 72%, 95% CI 0.42–1.0) and SUVmax of the predominant extra-nodal lesion of 3 (AUC 70.8% and 95% CI 0.23–1.0); therefore, SUVmax of higher than these values was related to stable or progressive disease, and lower levels than these values were related to complete or partial metabolic response based on Deauville 5-point scale and Lugano response criteria. Conclusions Early-stage interim PET-CT SUVmax of the predominant nodal and extra-nodal lesion could be a reliable parameter in predicting initial and final therapeutic outcome in lymphoma patients.https://doi.org/10.1186/s43055-024-01247-6Positron emission tomography/computed tomographyLymphoma18F-FDG PET/CTTherapeutic outcomePrognosis
spellingShingle Salma M. Borg
Gehad A. Saleh
Nihal M. Batouty
Amani Ezzat Mousa
Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
The Egyptian Journal of Radiology and Nuclear Medicine
Positron emission tomography/computed tomography
Lymphoma
18F-FDG PET/CT
Therapeutic outcome
Prognosis
title Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
title_full Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
title_fullStr Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
title_full_unstemmed Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
title_short Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
title_sort role of interim positron emission tomography computed tomography in assessment of lymphoma treatment response
topic Positron emission tomography/computed tomography
Lymphoma
18F-FDG PET/CT
Therapeutic outcome
Prognosis
url https://doi.org/10.1186/s43055-024-01247-6
work_keys_str_mv AT salmamborg roleofinterimpositronemissiontomographycomputedtomographyinassessmentoflymphomatreatmentresponse
AT gehadasaleh roleofinterimpositronemissiontomographycomputedtomographyinassessmentoflymphomatreatmentresponse
AT nihalmbatouty roleofinterimpositronemissiontomographycomputedtomographyinassessmentoflymphomatreatmentresponse
AT amaniezzatmousa roleofinterimpositronemissiontomographycomputedtomographyinassessmentoflymphomatreatmentresponse